mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.083 |
0.05 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.05 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.05 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.05 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |